Showing 141-150 of 4107 results for "".
The Whole Experience: 10 Tips for Increasing Surgical Conversion Rates
https://practicaldermatology.com/topics/practice-management/the-whole-experience-10-tips-for-increasing-surgical-conversion-rates/20573/How to develop practice-wide systems and processes to help deliver a unique and patient-centric experience to up conversion from consult to procedure.Top 5 Skincare Trends on Social Media: What is Truly “Verified?”
https://practicaldermatology.com/issues/june-2024/top-5-skincare-trends-on-social-media-what-is-truly-verified/26556/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.Noah Worcester 2024: Dr. Green and Dr. Weinstein on Medicare
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-green-and-dr-weinstein-medicare/24582/Noah Worcester 2024: Dr. Green and Dr. Weinstein on MedicareWhat Could Go Wrong with Fillers?
https://practicaldermatology.com/conferences/maui-derm-2024/what-could-go-wrong-with-fillers/20253/Joel L. Cohen, MD, explains the importance of understanding “what lies beneath” in order to more accurately evaluate post-procedure reactions and know how and when to intervene.What’s New With Neuromodulators?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-with-neuromodulators/20252/Joel L. Cohen, MD, discusses the currently available neuromodulators as well as what’s on the radar, including ready-to-use liquid toxins and more.Why It’s Critical to Distinguish Between Rosacea Subtypes for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/why-its-critical-to-distinguish-between-rosacea-subtypes-for-best-results/20245/In the Acne and Rosacea Updates symposium, Hilary Baldwin, MD, explained how she evaluates and treats rosacea with phenotypic therapies based on which aspects of the disease patients are most concerned about.Workplace Diversity: Spotting Opportunities and Overcoming Challenges
https://practicaldermatology.com/topics/practice-management/workplace-diversity-spotting-opportunities-and-overcoming-challenges/23762/An expert on workplace diversity and class bias shares insights to help all organizations improve.Why is CSF Different?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-is-csf-different/20124/Discover why CSF is different from other meetings. Attendees and faculty share their CSF experience and describe why they think the meeting and its new Nashville home make for “a great program.”What's your top travel destination dream?
https://practicaldermatology.com/topics/practice-management/whats-your-top-travel-destination-dream/20038/Misha Rosenbach, MD reflects on how the COVID-19 pandemic and concerns about climate change altered his perspective on travel destination dreams, as well as where he hopes to get back to one day.